Wolverine Trading, LLC Novo Cure LTD Transaction History

Wolverine Trading, LLC

$133 Billion
Q3 2025

A detailed history of Wolverine Trading, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Wolverine Trading, LLC holds 46,700 shares of NVCR stock, worth $528,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,700

Previous 29,900 56.19%

Holding current value

$528,644

Previous $532,000 13.35%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$14.54 - $33.41 $142,477 - $327,384	9,799 New	9,799 $292,000
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $144,916 - $201,739	11,668 New	11,668 $182,000
Q2 2023 Aug 23, 2023	BUY	$40.29 - $82.51 $271,030 - $555,044	6,727 New	6,727 $279,000
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $233,846 - $312,027	3,655 Added 30.77%	15,535 $1.14 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $44,057 - $58,041	648 Added 5.77%	11,880 $915,000

Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $26,092 - $41,443	-461 Reduced 3.94%	11,232 $813,000
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $109,954 - $154,502	1,828 Added 18.53%	11,693 $983,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $8,033 - $13,052	107 Added 1.1%	9,865 $788,000
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $1.19 Million - $1.99 Million	-10,242 Reduced 51.21%	9,758 $1.13 Million
Q2 2021 Aug 06, 2021	BUY	$130.4 - $225.58 $1.04 Million - $1.8 Million	7,969 Added 66.24%	20,000 $4.48 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $803,612 - $1.23 Million	-6,475 Reduced 34.99%	12,031 $1.51 Million
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $536,593 - $698,040	-9,381 Reduced 33.64%	18,506 $1.07 Million
Q1 2020 May 11, 2020	SELL	$57.05 - $95.75 $576,262 - $967,170	-10,101 Reduced 26.59%	27,887 $1.95 Million
Q4 2019 Feb 12, 2020	BUY	$68.3 - $93.8 $1.92 Million - $2.63 Million	28,089 Added 283.76%	37,988 $3.24 Million
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $282,514 - $446,652	-4,567 Reduced 31.57%	9,899 $727,000
Q2 2019 Aug 20, 2019	SELL	$42.22 - $63.23 $457,327 - $684,907	-10,832 Reduced 42.82%	14,466 $915,000
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $311,072 - $509,380	9,721 Added 62.41%	25,298 $1.33 Million
Q1 2018 May 15, 2018	BUY	$19.3 - $23.65 $300,636 - $368,396	15,577 New	15,577 $340,000

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

74.2M

Call Options Held

1.26M

Put Options Held

247K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.19B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Novo Cure LTD Transaction History